Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8722895 Prolyl hydroxylase inhibitors and method of use

Patent 8722895 was granted and assigned to Akebia Therapeutics on May, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 1 Feb, 2024

"update inverses"

edited on 1 Feb, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11883386 Prolyl hydroxylase inhibitors and methods of use

0

Edits on 3 Jan, 2024

"update inverses"

edited on 3 Jan, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11857543 Compositions and methods for treating anemia

0

Edits on 2 Dec, 2023

"Add patent abstract"

edited on 2 Dec, 2023

Edits made to:

Article (+319 characters)

Article

Patent abstract

The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.

Edits on 25 Sep, 2023

"Add patent inventor(s)"

edited on 25 Sep, 2023

Edits made to:

Infobox (+6 properties)

Infobox

Patent Inventor Names

Angelique Sun Boyer0

Artem G. Evdokimov0

Kenneth D. Greis0

Namal C. Warshakoon0

Richard M. Kawamoto0

Shengde Wu0

Edits on 2 Aug, 2023

"update inverses"

edited on 2 Aug, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11713298 Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid

0

Edits on 5 Jul, 2023

"update inverses"

edited on 5 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11690836 Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

0

Edits on 24 May, 2023

"Remove website redirecting to Patent Public Search front page"

edited on 24 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=08722895

Edits on 22 May, 2023

"Remove leading 0 from patent number"

edited on 22 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 08722895 Prolyl hydroxylase inhibitors and method of use US Patent 8722895 Prolyl hydroxylase inhibitors and method of use

Infobox

Patent Number

08722895

Patent Number

8722895

Edits on 19 Jun, 2022

"Entity importer update"

edited on 19 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=08722895

Edits on 23 Dec, 2021

"Created via: Entity Importer"

created this topic on 23 Dec, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 08722895 Prolyl hydroxylase inhibitors and method of use

Infobox

Is a

Current assignee

Akebia Therapeutics

Patent jurisdiction

United States Patent and Trademark Office

Patent number

08722895

Date of patent

May 13, 2014

Patent application number

13859574

Date Filed

April 9, 2013

Patent primary examiner

Find more entities like US Patent 8722895 Prolyl hydroxylase inhibitors and method of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool